SVP Bedoya-Toro purchases 1,000 shares of DRMA at $1.27; stock now -91.4% from 52-week high, company unprofitable.
Bedoya-Toro Munera Maria E, SVP of Regulatory Affairs, purchased 1,000 shares at $1.27, increasing her position from 12 shares to 1,012 shares. The transaction occurred at a significant discount to the 52-week high of $14.20; the stock currently trades at $1.22, having declined 47.0% over the past 90 days. The company posted a net loss of $-1.7M with a market capitalization of only $1.3M, indicating a distressed financial position. While the insider's position increased 8333.3% in percentage terms, the absolute dollar value of the purchase ($1.3K) is modest and the company's deep unprofitability limits the significance of a mid-level executive's small open-market buy.